赛默飞世尔将以高达94亿美元收购数据管理公司Clario

Core Viewpoint - Thermo Fisher Scientific announced the acquisition of private data management company Clario for up to $9.4 billion, aimed at strengthening its clinical trial research business amid a strong rebound in U.S. demand [1] Group 1: Acquisition Details - This acquisition marks Thermo Fisher's third significant purchase in 2023 [1] - The transaction is expected to be completed by early 2026 [1] - The first year post-acquisition is projected to increase adjusted earnings per share by $0.45 [1]